Clinical and cranial MRI features of female patients with ornithine transcarbamylase deficiency
Authors:
Open Access
- 1 August 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (33) , e16827
Abstract
Introduction: Ornithine transcarbamylase deficiency (OTCD) is a common metabolic disease of urea circulation disorder. We reported the clinical, brain imaging and genetic characteristics of 2 cases with OTCD. The patients’ clinical features, novel gene mutations, cranial MR specific imaging changes and blood tandem mass spectrometry, and urine gas chromatography-mass spectrometry were, retrospectively, analyzed. Patient concerns: Patient 1 was a 1.6-year-old female. She was admitted to the hospital with 2-months history of general irritability and disturbance of consciousness for a day. Patient 2 was a 3.7-year-old female. She was admitted to the hospital due to decline of language ability and irritability for 5 days. Blood tandem mass spectrometry and urine gas chromatography-mass spectrometry showed uracil and orotate increased significantly in urine while amino acids in the urea cycle ring were in the normal range. The features of brain MRI are consistent with those of urea circulatory disorders. Gene detection showed 1 novel mutation in the OTC gene (c.658C>T) in patient 1 and, 1 novel mutation (c.298+2T>G) in the OTC gene in patient 2. Diagnosis: Combined with metabolic screening and gene detection, both patients were diagnosed with OTCD. Interventions: The patients’ condition improved after following a low protein diet and receiving treatments for decreasing blood ammonia, energy supplement, correcting acid-base imbalance, and other symptomatic treatments. Outcomes: After prompt symptomatic treatment, the consciousness and cognition of the children improved. Besides, liver function also improved significantly. Conclusions: For patients with neurological symptoms and unexplained increase in transaminase and ammonia, OTCD should be considered as a possible diagnosis. Brain MRI can help the diagnosis of genetic metabolic encephalopathy and reflect the level of brain injury. Metabolic screening and genetic detection are helpful to make a confirmed diagnosis.Keywords
This publication has 16 references indexed in Scilit:
- Fatal coma in a young adult due to late-onset urea cycle deficiency presenting with a prolonged seizure: a case reportJournal of Medical Case Reports, 2015
- Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiencyJournal of Human Genetics, 2015
- [Report of a case with late-onset ornithine transcarbamylase deficiency with gas chromatography-mass spectrometry and DNA sequencing confirmation and literatures review].2015
- Genotype–Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation UpdateJournal of Genetics and Genomics, 2015
- Hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency due to a novel combined heterozygous mutationsThe American Journal of Emergency Medicine, 2015
- [Clinical characteristics and analysis of mass spectrometric data in patients with ornithine transcarbamylase deficiency].2014
- A longitudinal study of urea cycle disordersMolecular Genetics and Metabolism, 2014
- OTC Gene in Ornithine Transcarbamylase Deficiency: Clinical Course and Mutational Spectrum in Seven Korean PatientsPediatric Neurology, 2014
- Brain imaging in urea cycle disordersMolecular Genetics and Metabolism, 2010
- Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) geneHuman Mutation, 2006